We are using cookies to give you the best experience on our site. Cookies are files stored in your browser and are used by most websites to help personalise your web experience. By continuing to use our website without changing the settings, you are agreeing to our use of cookies.

  • Facebook
  • Twitter
  • Linked In
  • Google+
back top

Professor in Molecular Biology Cucchiarini Magali

Cucchiarini Magali

Saarland University Medical Center
Center of Experimental Orthopaedics
Homburg/Saar, Germany

Dr. Magali Cucchiarini, PhD, is an Associate Professor, Group Leader, and Vice-Director of the Center of Experimental Orthopaedics, Saarland University Medical Center, Homburg/Saar, Germany. She graduated from the University of Nice-Sophia Antipolis, Nice, France in 1992 (Biochemistry and Pharmacology) and received her PhD Thesis with summa cum laude from this University in 1995 (Virology and Molecular Biology). Before joining the Saarland University, Dr. Cucchiarini was a senior post-doctoral fellow for three years at Harvard (Harvard Institutes of Medicine), Boston, MA in the field of anti-HIV gene therapy. Prior to moving to the USA, she worked for two years at the University Hospital Inselsspital, Bern Switzerland on HCV immunology and vaccination at the Department of Internal Medicine.
Dr. Cucchiarini’s major research interest lies in generating novel cell-, gene-, and tissue engineered-based systems to treat orthopaedic disorders of the cartilage, bone, meniscus, tendons, and ligaments, with a focus on using the clinically relevant recombinant adeno-associated viral (rAAV) gene therapy vectors. Dr. Cucchiarini made over 138 national and international presentations, co-authored 13 books chapters and edited one book (Regenerative therapy for the musculoskeletal system using recombinant adeno-associated viral vectors), and is an author of over 150 peer-reviewed articles.
Dr. Cucchiarini sits on the Editorial Boards for OAC Open, Journal of Experimental Orthopaedics, BioMed Research International, Orthopedic Journal of Sports Medicine, Current Pharmaceutical Design, Journal of Rheumatology and Orthopaedics, and Journal of Organ Biology. She also serves as a reviewer for Acta Biomaterialia, American Journal of Sports Medicine, Arthritis & Rheumatology, Arthritis Research and Therapy, Biomaterials, Clinical Epigenetics, Current Gene Therapy, Current Pharmaceutical Biotechnology, Current Pharmaceutical Design, Current Stem Cell Research and Therapy, European Cells and Materials, Experimental Cell Research, Expert Opinion on Biological Therapy, Gene Therapy, International Journal of Molecular Sciences, Journal of Gene Medicine, Journal of Molecular Medicine, Journal of Orthopaedic Research, Molecular Medicine, Molecular Therapy, Nanomedicine, Osteoarthritis Cartilage, PLoS One, Regenerative Medicine, Scientific Reports, Stem Cell Research & Therapy, Stem Cells International, Tissue Engineering.

She serves as a Board Member of the Orthopaedic Research Society (ORS) and is involved at the ICRS and American Society of Gene & Cell Therapy (ASGCT).